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Abstract
Magnetic resonance imaging physics can be a complex and challenging topic for the practising cardiologist. Its evolving
nature and the increasing number of novel sequences used in clinical scanning have been topics of excellent reviews;
however, the basic understanding of physics underlying the creation of images remains difficult for many cardiologists.
In this review, we go back to the basic physics theories underpinning magnetic resonance and explain their application
and use in achieving good quality cardiac imaging, whilst describing established and novel magnetic resonance sequences.
By understanding these basic principles, it is anticipated that cardiologists and other health professionals will then
appreciate more advanced physics manuscripts on cardiac scanning and novel sequences.
Keywords
Cardiology, cardiovascular imaging agents/techniques, computed tomography and magnetic resonance imaging,
diagnostic testing
Introduction
In the last four decades, cardiovascular magnetic reso-
nance (CMR) has become increasingly popular. It has
been used to address complex clinical questions ranging
from myocardial function, perfusion defects and viabil-
ity, to quantification of valvular disease and identifica-
tion and monitoring of shunts in congenital heart
disease. CMR reports are a crucial aspect of practice
for cardiologists and other health professionals such as
cardiac surgeons and nurses; however, with the increas-
ing complexity of CMR sequences, it is also less easy to
follow and understand the physics underlying the new
sequences. In this review, we revisit the basic physics
principles underlying magnetic resonance imaging
(MRI) and describe established and novel MRI pulse
sequences. Once readers understand these basic physics
principles, they will be able to appreciate further manu-
scripts describing advanced physics concepts.
History of magnetic resonance imaging
The fundamentals of MRI were laid down in the 1940s,
when Felix Bloch proposed that atomic nuclei have
properties that allow them to behave like tiny mag-
nets.1 He postulated that a charged particle spinning
around its axis would have a magnetic field, or mag-
netic dipole moment, and published his theory in 1946.
This theory was verified experimentally, and in the
1960s, nuclear magnetic resonance spectrometers were
introduced; however, it took until the late 1970s for
magnetic resonance to be applied clinically. Raymond
Damadian proposed that the magnetic resonance prop-
erties of malignant tissue might differ from those of
normal tissue,2 and he produced an image of a
tumour in a rat in 1974. In 1977, the first image of a
human volunteer was acquired (Figure 1), requiring
over 4 h of scanning. The word ‘nuclear’ was dropped
around this time to avoid deterring patients from par-
ticipating in this new form of imaging. Over time, MRI
progressed from imaging static objects to moving
1Royal Brompton Hospital and Imperial College London, CMR Unit,
London, UK
2Norwich Medical School, University of East Anglia, Bob Champion
Research and Education, Norwich, UK
Corresponding author:
Vassilios S Vassiliou, Norwich Medical School, University of East Anglia,
Floor 2, Bob Champion Research and Education, James Watson Road,
Norwich NR4 7UQ, UK.
Email: v.vassiliou@rbht.nhs.uk
JRSM Cardiovascular Disease
Volume 7: 1–9
! The Author(s) 2018
Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/2048004018772237
journals.sagepub.com/home/cvd
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-
NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction
and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages
(https://us.sagepub.com/en-us/nam/open-access-at-sage).
objects, including the heart, with the aid of breath-
holding techniques, or ‘navigators’ to monitor breath-
ing motion. This enabled good quality anatomical
imaging of the heart, and later led to functional imag-
ing and myocardial tissue characterisation.
Essential MRI hardware
To enable MRI, the following specialised equipment is
required, for further information see Supplementary
material 1:
• The magnet – see Figure 2.
• Radiofrequency chain.
• Shim coils.
• Gradient coils.
• Computer hardware and software.
Magnetic resonance imaging physics:
Basic concepts
Our bodies are made of 80% water and each hydrogen
atom in the water molecule has two subatomic par-
ticles, the nucleus called the proton (H1) and an elec-
tron, with the proton being electrically charged (þ1)
and rotating around its own axis. The hydrogen atom
is the most useful MRI source, as it is the most abun-
dant element in the body. It is also the element with the
highest gyromagnetic ratio, which is given as the ratio
of its magnetic dipole moment to its angular momen-
tum; this offers an advantage in MRI.
Other nuclei can be used for MRI and spectroscopy,
such as: 13C, 17O, 19F and 31P.4,5 All of these are
currently used for research applications in CMR
spectroscopy.6,7
Outside a magnetic field, the nuclei of hydrogen
atoms are randomly oriented and provide a net mag-
netisation of zero (see Figure 3). However, when a sub-
ject is placed within a strong magnetic field, B0, the
nuclei tend to align in the direction of the field, pro-
ducing a net magnetisation, M, along the z-axis, paral-
lel to the scanner bore. This net magnetisation is then
manipulated to generate images.
The Larmor frequency
When inside a magnet, the protons tend to align, as
shown in Figure 3, and they also spin around their
Figure 1. The first MRI image of the human body, obtained in
1977. Figure reproduced with permission from Basic MRI Physics
by Blink.3
Figure 2. The components of a modern superconducting
magnet. Multiple vacuum vessels surround the core, acting as
temperature shields. These shields enable a slower boil off of the
liquid helium. A cooling pump runs continuously aiming to almost
eliminate the loss of helium.
Figure 3. Each proton, depicted by , spins around a ran-
domly oriented axis when there is no magnetic force, as shown
on the left. Inside a strong magnetic field B, however, as shown
on the right, protons tend to be pulled to align with the direction
of the magnetic field because of their magnetic dipole moments,
making the measurable but tiny nuclear magnetisation M that is
used for MRI, and the associated spins therefore also tend to be
aligned around that direction along the z axis.
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own axes, since a spin combined with an electrical
charge is classically viewed as having its own magnetic
dipole moment, like a small bar magnet. Much like a
gyroscope in a gravitational field, there is a fast spin;
however, under the torque imposed by gravity, the
gyroscope wobbles, or ‘precesses’, around the main
gravitational field direction. This classical interpreta-
tion is not considered realistic on an individual nuclear
spin scale; however, with enough nuclei considered
together the classical model of a precessing magnetisa-
tion vector has been shown to be valid, and is known as
the crowd behaviour model.8
The magnetisation within each microscopic volume
containing crowd behaviour of protons can be mod-
elled as precessing at the Larmor frequency, f, which
is proportional to the gyromagnetic ratio, c, and the
magnetic field strength, B0, as follows:
f ¼ c  B0
This is useful as it allows us to calculate the operat-
ing frequency of the MRI system. For example, the
Larmor frequency of a 1.5 T magnet is calculated
like so:
42:6 gyromagnetic ratio of hydrogen inMHz=Tð Þ
 1:5 magnetic field strength in Tð Þ
¼ 63:9MHz Larmor frequencyð Þ
This is important as it is required for successful
imaging, as discussed in the following section.
The term ‘spin isochromat’ is used to describe the
magnetisation vector from a microsopic region show-
ing uniform crowd behaviour; the term isochromat, or
‘same colour’, is used as all matter in the region has the
same frequency of emission. Spin isochromat is abbre-
viated as ‘spin’ in most MRI literature, and this con-
vention will be adopted henceforth in this review.
Resonance and excitation
The spins making up the net magnetisation vector have
an angular precession rate, or frequency, and a phase,
which describes the angular position relative to a fixed
point. If, for example, two spins start from the same
position but have slightly different frequencies, they
will become out-of-phase, and this out-of-phase shift,
or dephasing, will increase with time.
In preparation for scanning, the system measures the
Larmor frequency of the water in the region of interest:
namely, the thorax for cardiovascular applications. For
further information, see Supplementary material 2.
Relaxation
By rotating the net magnetisation into the x–y plane
(Figure 4), the constituent spins will also acquire
energy from the radiofrequency (RF) pulse; however,
the spins will gradually return to their original lower
energy states, much like a basketball player jumping to
put the ball in the basket will fall back to the ground
soon after. This process of returning to the lower
energy levels, to equilibrium, is called spin-lattice relax-
ation, or T1.
T1 relaxation. For the spins to return to equilibrium,
the energy they have absorbed from the RF pulse must
be released slowly back to their molecular environ-
ment. This manifests as a tiny amount of heat emission,
but also partly as the emitted electromagnetic signal
that is received for MRI. When the spins return to
equilibrium, the excitation is essentially reset to zero,
and the net magnetisation rotates back to align with the
z-axis, B0, as shown in Figure 4.
The recovery process is statistical over the crowd of
protons, somewhat like radioactive decay but with no
change in nuclear structure, only orientation, and a low
energy of emission far short of ionisation at clinical mag-
netic field strengths. Not all protons are bound in their
Figure 4. Following completion of the radiofrequency (RF)
pulse, the net magnetisation will have moved to the x–y axis
and then will start growing back on the z axis to return to
equilibrium. So, the initial growth on the z axis (panel (a)) will be
quickly succeeded by more growth (panel (b) and (c)) and the
magnetisation will ultimately reach equilibrium (panel (d)), where
all the magnetisation is along the z axis and there is no longer any
magnetisation in the x–y plane. The T1 parameter is also called
longitudinal or spin-lattice relaxation, as most of the energy is
released from the protons to the surrounding tissue; only a small
fraction is emitted as the rotating electromagnetic field received
for MRI.
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molecules in the same way, and some will have tighter or
weaker bonds than others; protons with tighter bonds
will allow more rapid release of energy and will thus
have a shorter T1. This leads to an exponential rise to a
maximum, familiar in physics (see Figure 5).
T2 relaxation. The second type of relaxation is T2
relaxation, a process independent of T1 relaxation,
but occurring simultaneously. While T1 involves
changes from the direction of the z-axis to the x–y
plane, T2 describes changes in the x–y plane. When
the RF pulse is applied, the magnetisation transits
into the x–y plane and the spins start to precess in
phase; immediately after transmission of the RF pulse
ends the net magnetisation vector, or transverse mag-
netisation, is rotating in the x–y plane around the
z-axis, as shown in Figure 6(a). However, underlying
this, the direct interaction between the spin magnetic
dipole moments, known as ‘spin-spin interaction’,
causes a submicroscopic dispersion in the apparent
Larmor frequency of each spin isochromat, and the
magnetisation vectors soon start to rotate at different
rates (Figure 6(b)–(d)).
Figure 5. The T1 relaxation curve. At time 0, immediately after the radiofrequency (RF) pulse, there is no magnetisation in the
z direction. But immediately after, the z-axis magnetisation starts to recover. The parameter T1 is defined as the time required for the
longitudinal magnetisation to reach 63% of the initial magnetisation. It is interesting to appreciate that this was the principle upon
which Damadian based his initial MR work in realising that some tumours may have a higher T1 than normal tissue.
2
Figure 6. The process of T2 relaxation following a radiofrequency pulse. All the vectors have different speeds and soon start pointing
in different directions (panels (a)–(d)). Although all protons are rotating around the z axis in the x–y plane, with time all vectors now
point in different directions (panel (e)). The process of transforming from totally in-phase, where all vectors align together, to totally
out-of-phase, where no vector is aligned together, is called T2 relaxation, whilst the total signal from all these vectors pointing in
different directions is near-zero.
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Like T1 relaxation, T2 relaxation causes a decaying
effect, but this time in the available transverse magnet-
isation detected by the receiver coil (see Figure 7).
Two physical reasons exist for the decay of the total
received Mxy signal: the spins may dephase relative to
each other due to genuine spin-spin interactions (T2),
or because they are in different magnetic field strengths
and are therefore precessing at different frequencies
(T2 prime, or T2
0). The T20 effect applies on a macro-
scopic scale, over the entirety of the patient, down to
subvoxel scale, due to excessive iron in tissues, for
example. Its impact is highly dependent on the physical
distance scale in question. The combined dephasing
effect of T2 and T2
0 is known as T2*, or T2 star,
where T2
0 is usually but not always faster than T2.
Image acquisition
During relaxation following the RF pulse, the protons
release their excess energy, partly as RF waves. These
waves must be captured in order to produce an image,
and this is achieved using a receiver coil, which is some-
times the same as the transmission coil. For safety, the
transmission coil is typically housed at a distance from
the patient, as it carries peak RF powers in the region
of 10,000 W in short pulses, which might become dan-
gerous. The receiver coil must also be positioned at or
near right angles to B0, as the precessing magnetisation
has an oscillating Mxy component only, which gener-
ates a weak oscillating magnetic field in the x–y plane.
Image creation and display
As shown in Figure 8, the RF pulse causes excitation,
followed by precession and relaxation, and from this
the RF waves are picked up by the receiver and fed into
a computer to produce an image.
The fundamental principle that makes a projection
or one-dimensional image of the patient can be imag-
ined as follows. When a signal is received in the pres-
ence of a gradient applied across the excited slice, it
contains high frequencies from one side of the patient
and low frequencies from the other. We can analyse the
spectrum of this signal by performing Fourier transfor-
mation, and this tells us how much tissue is at each
position across the magnet in the direction of the
applied gradient. This is called frequency encoding
of position.
We repeat this process, each time with a further
‘twist’ of signal phase along the other in-plane direc-
tion, the phase-encoding direction, to assemble a fre-
quency slope over the repeated steps. Further spectrum
analysis can then be performed to give positional infor-
mation in the phase-encode direction.
Basic cardiovascular magnetic resonance
pulse sequences
Spin echo
Spin echo pulse sequences acquire images during one
fixed phase of the cardiac cycle, the timing of which is
governed by a triggering delay after the R-wave.
Following the initial 90 RF pulse, the net
Figure 7. AT2 relaxation curve. Following the 90
 radiofrequency (RF) pulse, all the magnetisation flips into the x–y plane where it is
labelled Mxy. Initially all the spins are in the same phase; however, immediately after the RF pulse they start to become out of phase. T2
is the time taken for the total signal to decay to 37% of the original value. T2 usually occurs much faster than T1 and it is also called
spin-spin relaxation as it describes interactions between the protons. Once both T1 and T2 relaxation processess are finished the
original equilibrium is restored along the main magnetic field (B0).
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magnetisation starts to dephase due to T2* relaxation.
Then a second RF pulse at 180 follows, causing the
protons to rephase the T2
0 contribution of main field
non-uniformity at the ‘echo time’, recovering the inho-
mogeneous dephasing to leave pure T2 decay. Spin
echo images can have both T1- and T2-weighted prop-
erties: T2 weighting increases with longer echo times
while T1 weighting occurs if the 90–180
 acquisition
process is repeated before complete T1 recovery has
occurred. To minimise T1 weighting, it is necessary to
pause the pulse sequence so that it acquires only every
second or third cardiac cycle, depending on the
patient’s heart rate. Clinical applications of the
spin echo sequence include: obtaining anatomical
information, where blood appears darkened by a
flow-dependent preparation method;10 imaging for
myocarditis, pericarditis, cardiomyopathies, vasculitis
and cardiac tumours; and assessing myocardial scar
following gadolinium contrast administration.11,12
Cine imaging sequences
Gradient echo, or gradient recalled echo (GRE), imag-
ing is based on a single RF pulse, typically <90, avoid-
ing the additional time and motion sensitivity of a spin
echo 180 RF pulse. This sequence can be repeated
continuously, delivering an apparent functional cine
of the cardiac cycle. This is performed using a standard
gradient echo pulse sequence or a steady-state free-
precession (SSFP) sequence, which provides more
reliable contrast between blood and myocardium due
to the markedly longer T2 of blood than myocardium.
To complete imaging within a breath-hold, multiple
lines of the raw data are collected within each cardiac
cycle: this is especially useful for cardiac imaging of the
fast pumping heart, as it enables apparent dynamic cine
imaging, which is essentially a video of the heart pump-
ing from diastole to systole. It should be noted that the
images are assembled over multiple cycles under the
assumptions of adequate breath-holding and reliable
ECG detection in normal rhythm. Thanks to these
features, cine CMR delivers the reference standard esti-
mation for atrial and ventricular volumes and ejec-
tion fraction.
Late gadolinium enhancement imaging
Late gadolinium enhancement (LGE) imaging is highly
T1-sensitive gradient-echo imaging undertaken after
the administration of a gadolinium-based contrast
agent (Gd), which distributes in greater volumes in
fibrotic myocardium, where it demonstrates slower
washout times compared to normal myocardium.
Using a T1-sensitive gradient echo sequence, usually
10–15 min after the administration of Gd, it is possible
to demonstrate the abnormal deposition of the contrast
agent late after injection: focal regions of fibrosis
become enhanced, indicating replacement fibrosis,13–16
whereas normal myocardium remains black. Expertise
is needed to adjust the inversion–recovery null time so
Figure 8. A flowchart describing the process from sending the radiofrequency (RF) pulse to viewing the image. Nowadays, the
computing is based on a two-directional frequency analysis known as the 2D Fourier transform. A computing method for high speed
known as fast Fourier transform (FFT) was essential in the early days of MRI;9 however, this is no longer important in view of the
strong computing power that allows even a simple program for the Fourier Transform to be fast enough for images to appear almost
instantly after data collection ends.
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that normal myocardium is nulled and appears dark,
on the assumption that the disease sought has a focal
or localised pattern of distribution in the myocardium.
LGE has been a milestone in CMR, as the presence of
enhancement indicating various kinds of focal fibrosis
has been validated histologically, and has been
shown to be associated with higher risk of worse
outcome in a plethora of conditions including dilated
cardiomyopathy,17,18 valve disease19 and hypertrophic
cardiomyopathy.20
Myocardial T1 and T2 mapping
Recently there has been considerable interest in new
myocardial tissue characterisation techniques such as
T1 and T2 mapping, which are increasingly used in
research and clinical practice.21,22 It is therefore impor-
tant to comment on this topic in this review, and to
explain the utility of these relatively novel imag-
ing methods.
Myocardial T1 mapping. Although LGE is validated
for identification of focal fibrosis, it relies on clear dis-
tinction between normal and abnormal myocardial
tissue in order to be sensitive to abnormalities.
Therefore, a clinical need arose to have an imaging
biomarker that could identify subtle diffuse, ‘intersti-
tial’ fibrosis as opposed to the more definite focal,
‘replacement’ fibrosis. A clinically applicable method
of myocardial single-breath-hold T1-mapping, known
as MOdified Look-Locker Imaging or MOLLI,23 has
been introduced as a surrogate measure of interstitial
fibrosis, and similar methods have shown good
correlation with histologically identified collagen
volume fraction.24
MOLLI is ECG triggered and all images are
acquired in late diastole.25 The original MOLLI
sequence acquired 11 inversion–recovery images over
17 heart beats, and therefore was of limited use in
patients who could not perform a good breath hold.
Newer sequences obtain 8 inversion–recovery images in
11 heart beats, in a single breath hold of 8–12 s depend-
ing on the heart rate of the patient. MOLLI is based on
multiple inversion recovery images acquired both
before and after contrast administration. Following
motion correction and co-registration, a T1 map is
derived via pixel-wise curve fitting (see Figure 9), allow-
ing segmental analysis of T1 values. Native and post
Gd images can be used, and with the addition of hae-
matocrit measurements the extracellular volume frac-
tion can be derived as follows:
ECV ¼
1 haematocritð Þ 1T1myopost 1T1myopre
 
1
T1bloodpost
 1T1bloodpre
 
where ECV¼ extracellular volume fraction, T1
myo¼myocardial T1, T1 blood¼blood T1,
pre¼ native T1, post¼ following Gd administration.
The multiplication by (1haematocrit) represents the
blood volume of distribution and converts the equation
to myocardial ECV from partition coefficient;25 this
has proved useful in cardiomyopathies,26 valve dis-
ease27 and myocardial infarction.28
Figure 9. Native and post-gadolinium (Gd) T1 maps. Using the native and post Gd T1 values for blood and myocardium, and
incorporating haematocrit, the extracellular volume fraction (ECV) can be calculated for the corresponding slice location with the
formula described in the text. The yellow crescent and circle represent the regions of interest from which T1 values are measured,
in the myocardium and blood pool, respectively.
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Myocardial T2 mapping. Today, T2-weighted spin-
echo methods are popular for assessing pathologies
such as acute myocardial infarction and myocarditis.29
These techniques are qualitative, and are subject to pit-
falls such as poor signal-to-noise and artefacts relating
to coil sensitivity variations,30 slow-flowing blood adja-
cent to hypokinetic myocardium and poor pulse
sequence timing relative to the cardiac cycle. To miti-
gate these problems, quantitative T2 mapping techni-
ques have been proposed.29 These are similar to T1
mapping techniques in that several T2-weighted
images are acquired in the same cardiac phase over
multiple heartbeats, and pixelwise curve fitting is per-
formed to visualise the variation of T2 across the myo-
cardium. This method proves particularly useful for
imaging myocardial oedema associated with inflamma-
tion; however, it does not have the diverse applications
of T1 mapping, and is thus less-frequently used.
Cardiovascular magnetic resonance
safety considerations
In terms of imaging examinations, CMR is thought to
be a safe test, since it does not apply ionising radiation.
As such it is free from concerns about neoplasia asso-
ciated with other forms of imaging such fluoroscopical-
ly guided invasive cardiac angiography and computed
tomography; however, there are cautions and contra-
indications to CMR, relating to the paramagnetic
agents used, patients with implantable devices and
some more recent concerns regarding a theoretical
association with neoplasia. These are discussed further
in Supplementary material 3.
Conclusion
Modern CMR machines have evolved and improved
considerably, allowing faster and better imaging, but
many of the fundamental principles behind MR scan-
ning have remained the same since the late 1970s. Well-
established sequences for cardiac anatomy and func-
tion have been complemented by myocardial tissue
characterisation with LGE, and are now further sup-
plemented with T1 mapping towards more complete
phenotypic characterisation of patients, providing
diagnostic and prognostic information. This review
has offered a summary of these methods, providing
the reader with a gateway to more detailed articles.
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